IXS - Innexus Biotechnology Inc (TSXV) - Page 31

What is the potential sp of this a year from now and 5 years from now?

thats the million dollar question (literally)

We will have human trials this year. So if those come back positive and the company proves even further there technology is better than multibillion dollar drugs, then what value do you put on it??

Personally I think it will be well north of $1. Buying this stock in ones RRSP could cause early retirement. At some point it will get bought out. But just all my opinion

ixs

In my opinion IXS is sitting on a very hot commodity here folks.
All the trials done to date have had outstanding results and the overall value of this technology is skyrocketing . I am still a buyer here at 18.5 as I have been for the past 2 years . Have yet to sell a single share . I am still waiting for some negativity but it looks more and more like it will never come to pass.

ixs

It will be interesting to see how ixs trades today across the border. There was not a lot of volume there yesterday. Come on now we are sitting at 18.5 after all these milestones . I quess its all about financing and working capital. The big companies will want a piece of this technology IMO.

ixs

today,s Phoenix buisness journal.

Jeff Morhet, chairman and CEO of InNexus Biotechnology Inc., has been a strong proponent of collaborations. He created ThirdBiotech Research Group to help fledgling biotechs find lab space at reduced costs.

“We’ve got to rely on these collaborations,” he said. “2009 will be a Darwinian year. As most people understand Darwinism, it’s not the strongest that survive, it’s the most adaptable.”

Morhet said weaker biotech companies will die out this year.

“It will probably weed out some of the good companies during this process,” he said. “It’s also the reason why we need to collaborate and partner and merge — not just companies, but sometimes our ideas.”

InNexus raised more than $25 million in 2008 and signed its second deal with New York-based Royalty Pharma, giving the drug development company a $17.5 million commitment to finance its cancer drugs. Also last year, the company announced it was commencing development of a drug for colorectal cancer.

“This comes back to the heart of good biotechs and good technology companies as a whole,” said Morhet. “You have got to be able to create assets that are valuable to the shareholder.”

Hopefully we get the news on RP monies now

ixs

lets see if the tide turns here this pm and we start to see some buying.
this stock can,t stay at 17 . Too much upside IMO

i think yesterdays news was huge for the company in that it proved up "Proof of Principle" for the DXL Technology. I would expect (and I believe the company expects) that they will get similar results with all the drugs they apply the DXL technology too. So far they are working on 3 separate multibillion dollar annual sales drugs, rituxan, herceptin, and erbitrux. And so far 3 for 3 with all the preclinical studies completed.

If all goes according to the plan of the company we will be doing Phase I human clinical trials this year.

So then what is the value of this company. I don't think we will be concerned about 5 or 6 cent moves.

The bluesky potential is better than any stock I can see out there.

ixs

You got to love manipulators , daytraders , shorters and the like .
I added a bunch more today cheap.

ixs

looks like they want to bring it down to 14 cents at the close today. IMO
More cheap shares.

Bought too high.....again

ixs

To high is relavent to the time frame and your goals . i have been buying for two years. This is long term for me. Patience is the key to prosperity here.

Updated chart on page 3. Today's indecision was on low volume. Perhaps a little sideways tomorrow but I suspect this run still has some MOMO left in it.

management and board of directors have now put in $1MM of their own after tax dollars over the last 3 months. Nice to see them support the stock like that.
GLTA

low volume again today! hit .19 i think !

Going for .125 and .13 today.

Doubled up my position the other day and contemplating adding more tomorrow...

The CEO is presenting at a conference next week and looking to hear news on the Royal Pharma agreement

taking off this afternoon, not huge volume yet but good bid support

not a bad day at all!

Next week should be a big week for IXS it seems like they like to put out news when at conferences/presentations.

I am probably weighted a little heavy with this stock but bout another 10000 today.